{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:25:38Z","timestamp":1771478738141,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872192"],"award-info":[{"award-number":["81872192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702685"],"award-info":[{"award-number":["81702685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018M632266"],"award-info":[{"award-number":["2018M632266"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Young Talent Foundation of Jiangsu Provincial Health Department"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Accumulating evidences indicate that circular RNAs (circRNAs), a subclass of noncoding RNAs, play important role in regulating gene expression in eukaryotes. Hsa_circ_0046263 (circ-0046263) was found aberrantly expressed in nasopharyngeal carcinoma (NPC), but its role in tumor growth and metastasis remains largely unclear. Sanger sequencing, RNase R assay, and nucleic acid electrophoresis were conducted to verify the identification of circ-0046263. Nuclear separation and fluorescence in situ hybridization (FISH) assays were used to determine the localization of circ-004263. Dual luciferase reporter and RNA immunoprecipitation (RIP) were employed to confirm the binding of circ-0046263 with miR-133a-5p. Colony formation, proliferation, wound healing, transwell, western blot, and in vivo tumor growth and metastasis assays were performed to assess the roles of circ-0046263, miR-133a-5p, IGFBP3 and their interactions in NPC cells. Circ-0046263 was upregulated in both NPC cell lines and tissues. The in vitro functional studies revealed that knockdown of circ-0046263 inhibited the proliferation, invasion, and migration of NPC cells, whereas its overexpression produced the opposite result. In vivo experiments indicated that knockdown or overexpression of circ-0046263 attenuated or promoted tumor growth and metastasis, respectively. Mechanistically, circ-0046263 could act as a miRNA sponge to absorb miR-133a-5p and upregulate the expression of miRNA downstream target IGFBP3. In addition, miR-133a-5p inhibition or IGFBP3 overexpression could rescue the malignant behavior induced by circ-0046263 silencing. Finally, circ-0046263 plays a tumor-promoting role in NPC to enhance malignant behavior through the miR-133a-5p\/IGFBP3 axis, which could be a potential target for NPC therapy.<\/jats:p>","DOI":"10.1038\/s41419-020-02785-3","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T05:04:17Z","timestamp":1595480657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3"],"prefix":"10.1038","volume":"11","author":[{"given":"Li","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-2391","authenticated-orcid":false,"given":"Jifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"2785_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394, 64\u201380 (2019).","journal-title":"Lancet"},{"key":"2785_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-030-22254-3_2","volume":"1164","author":"HM Lee","year":"2019","unstructured":"Lee, H. M., Okuda, K. S., Gonzalez, F. E. & Patel, V. Current perspectives on nasopharyngeal carcinoma. Adv. Exp. Med. Biol. 1164, 11\u201334 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2785_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OTT.S188148","volume":"12","author":"F Perri","year":"2019","unstructured":"Perri, F. et al. Management of recurrent nasopharyngeal carcinoma: current perspectives. OncoTargets Ther. 12, 1583\u20131591 (2019).","journal-title":"OncoTargets Ther."},{"key":"2785_CR4","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.ctrv.2019.101890","volume":"79","author":"AWM Lee","year":"2019","unstructured":"Lee, A. W. M. et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat. Rev. 79, 101890 (2019).","journal-title":"Cancer Treat. Rev."},{"key":"2785_CR5","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee, A. W., Ma, B. B., Ng, W. T. & Chan, A. T. Management of nasopharyngeal carcinoma: current practice and future perspective. J. Clin. Oncol. 33, 3356\u20133364 (2015).","journal-title":"J. Clin. Oncol."},{"key":"2785_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-017-0793-9","volume":"25","author":"HD Zhang","year":"2018","unstructured":"Zhang, H. D., Jiang, L. H., Sun, D. W., Hou, J. C. & Ji, Z. L. CircRNA: a novel type of biomarker for cancer. Breast Cancer 25, 1\u20137 (2018).","journal-title":"Breast Cancer"},{"key":"2785_CR7","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.7150\/jca.30828","volume":"10","author":"Y Yin","year":"2019","unstructured":"Yin, Y. et al. Emerging roles of circRNA in formation and progression of cancer. J. Cancer 10, 5015\u20135021 (2019).","journal-title":"J. Cancer"},{"key":"2785_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1878-0261.12468","volume":"13","author":"L Verduci","year":"2019","unstructured":"Verduci, L., Strano, S., Yarden, Y. & Blandino, G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol. Oncol. 13, 669\u2013680 (2019).","journal-title":"Mol. Oncol."},{"key":"2785_CR9","doi-asserted-by":"publisher","unstructured":"Li, R. et al. CircRNA: a rising star in gastric cancer. Cell. Mol. Life Sci. https:\/\/doi.org\/10.1007\/s00018-019-03345-5 (2019).","DOI":"10.1007\/s00018-019-03345-5"},{"key":"2785_CR10","first-page":"1183","volume":"55","author":"KL Harper","year":"2019","unstructured":"Harper, K. L., McDonnell, E. & Whitehouse, A. CircRNAs: From anonymity to novel regulators of gene expression in cancer (Review). Int. J. Oncol. 55, 1183\u20131193 (2019).","journal-title":"Int. J. Oncol."},{"key":"2785_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen, L. L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 17, 205\u2013211 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2785_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01216-w","volume":"8","author":"CY Yu","year":"2017","unstructured":"Yu, C. Y. et al. The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency. Nat. Commun. 8, 1149 (2017).","journal-title":"Nat. Commun."},{"key":"2785_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/cdd.2017.61","volume":"24","author":"K Wang","year":"2017","unstructured":"Wang, K. et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Differ. 24, 1111\u20131120 (2017).","journal-title":"Cell Death Differ."},{"key":"2785_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/jcb.27403","volume":"120","author":"XB Chen","year":"2019","unstructured":"Chen, X. B., Li, W. & Chu, A. X. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1. J. Cell. Biochem. 120, 470\u2013480 (2019).","journal-title":"J. Cell. Biochem."},{"key":"2785_CR15","first-page":"929","volume":"24","author":"S Liu","year":"2019","unstructured":"Liu, S., Chen, J., Zhang, T. & Chen, H. MicroRNA-133 inhibits the growth and metastasis of the human lung cancer cells by targeting epidermal growth factor receptor. J. BUON 24, 929\u2013935 (2019).","journal-title":"J. BUON"},{"key":"2785_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biopha.2018.05.043","volume":"104","author":"TF Li","year":"2018","unstructured":"Li, T. F., Liu, J. & Fu, S. J. The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and metastasis of pancreatic carcinoma. Biomed. Pharmacother. = Biomed. Pharmacother. 104, 145\u2013150 (2018).","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"2785_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cbin.10745","volume":"41","author":"W Hao","year":"2017","unstructured":"Hao, W. et al. Propofol protects against hepatic ischemia\/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Cell Biol. Int. 41, 495\u2013504 (2017).","journal-title":"Cell Biol. Int."},{"key":"2785_CR18","volume":"11","author":"AA Almobarak","year":"2019","unstructured":"Almobarak, A. A., Jebreel, A. B. & Abu-Zaid, A. Molecular targeted therapy in the management of recurrent and metastatic nasopharyngeal carcinoma: a comprehensive literature review. Cureus 11, e4210 (2019).","journal-title":"Cureus"},{"key":"2785_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","volume":"98","author":"J Zang","year":"2020","unstructured":"Zang, J., Lu, D. & Xu, A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J. Neurosci. Res. 98, 87\u201397 (2020).","journal-title":"J. Neurosci. Res."},{"key":"2785_CR20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/jcp.27041","volume":"234","author":"Z Ke","year":"2019","unstructured":"Ke, Z., Xie, F., Zheng, C. & Chen, D. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition. J. Cell. Physiol. 234, 1699\u20131706 (2019).","journal-title":"J. Cell. Physiol."},{"key":"2785_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0959-y","volume":"19","author":"Q Zhong","year":"2019","unstructured":"Zhong, Q., Huang, J., Wei, J. & Wu, R. Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma. Cancer Cell Int. 19, 252 (2019).","journal-title":"Cancer Cell Int."},{"key":"2785_CR22","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.7150\/jca.31167","volume":"10","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. Regulatory mechanisms and clinical perspectives of circRNA in digestive system neoplasms. J. Cancer 10, 2885\u20132891 (2019).","journal-title":"J. Cancer"},{"key":"2785_CR23","doi-asserted-by":"crossref","unstructured":"Dori, M. & Bicciato, S. Integration of bioinformatic predictions and experimental data to identify circRNA-miRNA Associations. Genes 10, 642 (2019).","DOI":"10.3390\/genes10090642"},{"key":"2785_CR24","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1096\/fj.11-198598","volume":"26","author":"M Natsuizaka","year":"2012","unstructured":"Natsuizaka, M. et al. Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1alpha-mediated mRNA transcription and continuous protein synthesis. FASEB J. 26, 2620\u20132630 (2012).","journal-title":"FASEB J."},{"key":"2785_CR25","first-page":"29","volume":"4","author":"M Natsuizaka","year":"2014","unstructured":"Natsuizaka, M. et al. IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. Am. J. Cancer Res. 4, 29\u201341 (2014).","journal-title":"Am. J. Cancer Res."},{"key":"2785_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081423","volume":"8","author":"M Xue","year":"2013","unstructured":"Xue, M. et al. IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer. PLoS ONE 8, e81423 (2013).","journal-title":"PLoS ONE"},{"key":"2785_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4149\/neo_2018_170720N491","volume":"65","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Meta-analysis of the association of IGFBP3 and IGF1 polymorphisms with susceptibility to colorectal cancer. Neoplasma 65, 855\u2013864 (2018).","journal-title":"Neoplasma"},{"key":"2785_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/cen.13499","volume":"88","author":"YX Chan","year":"2018","unstructured":"Chan, Y. X. et al. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1. Clin. Endocrinol. 88, 333\u2013340 (2018).","journal-title":"Clin. Endocrinol."},{"key":"2785_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161009","volume":"11","author":"T Yoneyama","year":"2016","unstructured":"Yoneyama, T. et al. Identification of IGFBP2 and IGFBP3 as compensatory biomarkers for CA19-9 in early-stage pancreatic cancer using a combination of antibody-based and LC-MS\/MS-based proteomics. PLoS ONE 11, e0161009 (2016).","journal-title":"PLoS ONE"},{"key":"2785_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2217\/bmm.13.112","volume":"7","author":"AJ Prager","year":"2013","unstructured":"Prager, A. J. et al. Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer. Biomark. Med. 7, 831\u2013841 (2013).","journal-title":"Biomark. Med."},{"key":"2785_CR31","doi-asserted-by":"crossref","unstructured":"Mayo, J. C. et al. IGFBP3 and MAPK\/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer. J. Pineal Res. 62, e12373 (2017).","DOI":"10.1111\/jpi.12373"},{"key":"2785_CR32","doi-asserted-by":"publisher","first-page":"dju085","DOI":"10.1093\/jnci\/dju218","volume":"106","author":"Y Cao","year":"2014","unstructured":"Cao, Y. et al. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J. Natl. Cancer Inst. 106, dju085 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"2785_CR33","doi-asserted-by":"crossref","unstructured":"Fan, X. et al. B-Myb mediates proliferation and migration of non-small-cell lung cancer via suppressing IGFBP3. Int. J. Mol. Sci. 19, 1479 (2018).","DOI":"10.3390\/ijms19051479"},{"key":"2785_CR34","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.2147\/CMAR.S169222","volume":"10","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Relationship between IGF2BP2 and IGFBP3 polymorphisms and susceptibility to non-small-cell lung cancer: a case-control study in Eastern Chinese Han population. Cancer Manag. Res. 10, 2965\u20132975 (2018).","journal-title":"Cancer Manag. Res."},{"key":"2785_CR35","first-page":"1165","volume":"9","author":"Y Sun","year":"2015","unstructured":"Sun, Y., Ai, X., Shen, S., Gu, L. & Lu, S. Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases. Patient Preference Adher. 9, 1165\u20131169 (2015).","journal-title":"Patient Preference Adher."},{"key":"2785_CR36","doi-asserted-by":"publisher","first-page":"41837","DOI":"10.18632\/oncotarget.5995","volume":"6","author":"YC Yen","year":"2015","unstructured":"Yen, Y. C. et al. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin beta1. Oncotarget 6, 41837\u201341855 (2015).","journal-title":"Oncotarget"},{"key":"2785_CR37","doi-asserted-by":"publisher","first-page":"15043","DOI":"10.1007\/s13277-016-5400-8","volume":"37","author":"L Bao","year":"2016","unstructured":"Bao, L. et al. Overexpression of IGFBP3 is associated with poor prognosis and tumor metastasis in nasopharyngeal carcinoma. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 37, 15043\u201315052 (2016).","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"2785_CR38","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M. & Medici, D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7, re8 (2014).","journal-title":"Sci. Signal."},{"key":"2785_CR39","first-page":"321","volume":"42","author":"L Yang","year":"2019","unstructured":"Yang, L. et al. Up-regulation of insulin-like growth factor binding protein-3 is associated with brain metastasis in lung adenocarcinoma. Mol. Cells 42, 321\u2013332 (2019).","journal-title":"Mol. Cells"},{"key":"2785_CR40","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/carcin\/bgq108","volume":"31","author":"M Natsuizaka","year":"2010","unstructured":"Natsuizaka, M. et al. Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 31, 1344\u20131353 (2010).","journal-title":"Carcinogenesis"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02785-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:00:31Z","timestamp":1760086831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02785-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2785"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02785-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"562"}}